Mar. 26, 2026
FDA Warns ImmunityBio Over Misleading Cancer Drug Claims
Regulators object to CEO's statements about Anktiva's capabilities on podcast and in TV ad
Mar. 24, 2026
Immune Cells Hunt, Destroy Tumors in Mice Study
Technique transforms immune cells into cancer-seeking bloodhounds, overcoming roadblock in immunotherapy for solid tumors
Mar. 24, 2026
IASO Bio Receives Clearance from Japan's PMDA for CAR-T Therapy Clinical Trial
The company's BCMA-targeted CAR-T cell therapy Equecabtagene Autoleucel will be evaluated in relapsed/refractory multiple myeloma patients.
Mar. 23, 2026
Amanda Peet Reflects on Fighting Cancer Amid Parental Deaths
The actor opens up about her breast cancer diagnosis and the simultaneous grief of losing her parents.
Mar. 22, 2026
Researchers Develop New Approaches to Harness the Body's Immune System Against Cancer
Breakthroughs in immunotherapy and cell reprogramming offer promise for more effective, accessible cancer treatments.
Mar. 22, 2026
IDEAYA Biosciences Announces Upcoming Investor Events, Darovasertib Trial Update
Company provides guidance on timing of topline data release from Phase 2/3 OptimUM-02 trial in metastatic uveal melanoma
Mar. 21, 2026
Actress Amanda Peet Reveals Breast Cancer Diagnosis
Peet's parents were in hospice care as she navigated her own health crisis.
Mar. 21, 2026
Actress Amanda Peet Reveals Breast Cancer Diagnosis
Peet opened up about her stage I cancer diagnosis and treatment amid her parents' hospice care.
Mar. 20, 2026
UCSF Leads the Way in Lynch Syndrome Research and Care
Specialized center provides coordinated, multidisciplinary care and access to cutting-edge prevention trials.
Mar. 19, 2026
Context Therapeutics to Present Poster at AACR Annual Meeting
The biopharmaceutical company will highlight preclinical data on its Nectin-4 x CD3 T cell engaging bispecific antibody.
Mar. 18, 2026
Man Shares Perspective on Undergoing Breast Cancer Screening
Writer Zachary Bernstein describes feeling like an outsider in the 'woman's world' of mammograms.
Mar. 18, 2026
Guardant Health Touts Growth in Cancer Diagnostics at Barclays Conference
Executives highlight opportunities in treatment selection, minimal residual disease testing, and colorectal cancer screening
Mar. 17, 2026
Zymeworks Presents New Cancer Drug Candidates at AACR
Biotech company showcases clinical and preclinical data on antibody-drug conjugate programs, including novel RAS-targeting platform.
Mar. 17, 2026
Ovarian Cancer Survivor Turns Pain Into Purpose
Rachel reflects on community, advocacy, and living a life shaped by purpose—not just diagnosis.
Mar. 17, 2026
Immuneering Presents Molecular Data on Atebimetinib at AACR Meeting
Poster shows Deep Cyclic Inhibitor of MEK may overcome resistance in RAS-mutant tumors
Mar. 17, 2026
Guardant Health Highlights Growth Plans for Cancer Tests at Leerink Conference
Company touts new Quest partnership, Guardant360 expansion, and upcoming regulatory milestones
Mar. 17, 2026
Avacta Announces Preclinical and Translational Presentations of pre|CISION® Platform Candidates at 2026 AACR Annual Conference
Biopharmaceutical company to showcase tumor-activated oncology delivery platform at leading cancer research event
Mar. 17, 2026
Guardant Health Touts Hypergrowth in Guardant360, Reveal MRD and Shield CRC
Executives outline growth drivers across treatment selection, minimal residual disease testing, and colorectal cancer screening at Barclays conference.
Mar. 17, 2026
Avacta Announces Preclinical and Translational Presentations of pre|CISION Platform Candidates at AACR 2026
Biopharmaceutical company Avacta to showcase tumor-activated oncology delivery platform at major cancer research conference.
Mar. 16, 2026
Guardant Health, Harris Poll Survey Shows 92% of Eligible Americans Believe Colorectal Cancer Blood Tests Should be Accessible and Covered
Survey highlights strong support for expanded access to innovative blood-based colorectal cancer screening options like Guardant's FDA-approved Shield test.
